Global IVD Market Overview:
Global IVD Market Report 2025 provides a comprehensive analysis of the industry, covering key factors such as market trends, growth drivers, developments, size, and dynamics. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of IVD involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the IVD Market
The IVD Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for IVD Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting the growth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study IVD Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, IVD market has been segmented into:
Reagents and Kits
Instruments
Data Management Software
Services
By Application, IVD market has been segmented into:
Diabetes
Infectious Diseases
Oncology/Cancer
Cardiology
Nephrology
Autoimmune Diseases
Drug Testing/Pharmacogenomics
HIV/AIDS
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East and Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The IVD market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the IVD market.
Top Key Players Covered in IVD market are:
Roche Diagnostics
Danaher Corporation
Abbott Laboratories
Siemens
Sysmex
Thermo Fisher Scientific
Becton
Dickinson and Company
Biomérieux Sa
Bio-Rad Laboratories
Johnson and Johnson
Agilent Technologies
Qiagen
Diasorin
Ortho Clinical Diagnostics
Research Methodology:
Our report provides a detailed breakdown of the market, divided into segments like Type and Application, each with its own sub-categories. We also examine major competitors, looking at their market size, share, and recent activities such as mergers, acquisitions, and partnerships. This helps new and existing businesses in the IVD Market understand the competitive landscape and plan their strategies. We collect our data through two main methods:
1. Primary Research: Direct interviews with industry experts and insights from top research analysts.
2. Secondary Research: Information from company annual reports and public records.
We then analyze this data using proven methods like SWOT analysis, PORTER's Five Forces model, and PESTLE analysis to ensure accuracy and reliability.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: IVD Market by Type
4.1 IVD Market Snapshot and Growth Engine
4.2 IVD Market Overview
4.3 Reagents and Kits
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Reagents and Kits: Geographic Segmentation Analysis
4.4 Instruments
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Instruments: Geographic Segmentation Analysis
4.5 Data Management Software
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Data Management Software: Geographic Segmentation Analysis
4.6 Services
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Services: Geographic Segmentation Analysis
Chapter 5: IVD Market by Application
5.1 IVD Market Snapshot and Growth Engine
5.2 IVD Market Overview
5.3 Diabetes
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Diabetes: Geographic Segmentation Analysis
5.4 Infectious Diseases
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Infectious Diseases: Geographic Segmentation Analysis
5.5 Oncology/Cancer
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Oncology/Cancer: Geographic Segmentation Analysis
5.6 Cardiology
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Cardiology: Geographic Segmentation Analysis
5.7 Nephrology
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Nephrology: Geographic Segmentation Analysis
5.8 Autoimmune Diseases
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Autoimmune Diseases: Geographic Segmentation Analysis
5.9 Drug Testing/Pharmacogenomics
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.9.3 Key Market Trends, Growth Factors and Opportunities
5.9.4 Drug Testing/Pharmacogenomics: Geographic Segmentation Analysis
5.10 HIV/AIDS
5.10.1 Introduction and Market Overview
5.10.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.10.3 Key Market Trends, Growth Factors and Opportunities
5.10.4 HIV/AIDS: Geographic Segmentation Analysis
5.11 Others
5.11.1 Introduction and Market Overview
5.11.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.11.3 Key Market Trends, Growth Factors and Opportunities
5.11.4 Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 IVD Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ROCHE DIAGNOSTICS
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 DANAHER CORPORATION
6.4 ABBOTT LABORATORIES
6.5 SIEMENS
6.6 SYSMEX
6.7 THERMO FISHER SCIENTIFIC
6.8 BECTON
6.9 DICKINSON AND COMPANY
6.10 BIOMÉRIEUX SA
6.11 BIO-RAD LABORATORIES
6.12 JOHNSON and JOHNSON
6.13 AGILENT TECHNOLOGIES
6.14 QIAGEN
6.15 DIASORIN
6.16 ORTHO CLINICAL DIAGNOSTICS
Chapter 7: Global IVD Market By Region
7.1 Overview
7.2. North America IVD Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Reagents and Kits
7.2.4.2 Instruments
7.2.4.3 Data Management Software
7.2.4.4 Services
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Diabetes
7.2.5.2 Infectious Diseases
7.2.5.3 Oncology/Cancer
7.2.5.4 Cardiology
7.2.5.5 Nephrology
7.2.5.6 Autoimmune Diseases
7.2.5.7 Drug Testing/Pharmacogenomics
7.2.5.8 HIV/AIDS
7.2.5.9 Others
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe IVD Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Reagents and Kits
7.3.4.2 Instruments
7.3.4.3 Data Management Software
7.3.4.4 Services
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Diabetes
7.3.5.2 Infectious Diseases
7.3.5.3 Oncology/Cancer
7.3.5.4 Cardiology
7.3.5.5 Nephrology
7.3.5.6 Autoimmune Diseases
7.3.5.7 Drug Testing/Pharmacogenomics
7.3.5.8 HIV/AIDS
7.3.5.9 Others
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe IVD Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Reagents and Kits
7.4.4.2 Instruments
7.4.4.3 Data Management Software
7.4.4.4 Services
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Diabetes
7.4.5.2 Infectious Diseases
7.4.5.3 Oncology/Cancer
7.4.5.4 Cardiology
7.4.5.5 Nephrology
7.4.5.6 Autoimmune Diseases
7.4.5.7 Drug Testing/Pharmacogenomics
7.4.5.8 HIV/AIDS
7.4.5.9 Others
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific IVD Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Reagents and Kits
7.5.4.2 Instruments
7.5.4.3 Data Management Software
7.5.4.4 Services
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Diabetes
7.5.5.2 Infectious Diseases
7.5.5.3 Oncology/Cancer
7.5.5.4 Cardiology
7.5.5.5 Nephrology
7.5.5.6 Autoimmune Diseases
7.5.5.7 Drug Testing/Pharmacogenomics
7.5.5.8 HIV/AIDS
7.5.5.9 Others
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East and Africa IVD Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Reagents and Kits
7.6.4.2 Instruments
7.6.4.3 Data Management Software
7.6.4.4 Services
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Diabetes
7.6.5.2 Infectious Diseases
7.6.5.3 Oncology/Cancer
7.6.5.4 Cardiology
7.6.5.5 Nephrology
7.6.5.6 Autoimmune Diseases
7.6.5.7 Drug Testing/Pharmacogenomics
7.6.5.8 HIV/AIDS
7.6.5.9 Others
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America IVD Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Reagents and Kits
7.7.4.2 Instruments
7.7.4.3 Data Management Software
7.7.4.4 Services
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Diabetes
7.7.5.2 Infectious Diseases
7.7.5.3 Oncology/Cancer
7.7.5.4 Cardiology
7.7.5.5 Nephrology
7.7.5.6 Autoimmune Diseases
7.7.5.7 Drug Testing/Pharmacogenomics
7.7.5.8 HIV/AIDS
7.7.5.9 Others
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
IVD Scope:
|
Report Data
|
IVD Market
|
|
IVD Market Size in 2025
|
USD XX million
|
|
IVD CAGR 2025 - 2032
|
XX%
|
|
IVD Base Year
|
2024
|
|
IVD Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Roche Diagnostics, Danaher Corporation, Abbott Laboratories, Siemens, Sysmex, Thermo Fisher Scientific, Becton, Dickinson and Company, Biomérieux Sa, Bio-Rad Laboratories, Johnson and Johnson, Agilent Technologies, Qiagen, Diasorin, Ortho Clinical Diagnostics.
|
|
Key Segments
|
By Type
Reagents and Kits
Instruments
Data Management Software
Services
By Applications
Diabetes
Infectious Diseases
Oncology/Cancer
Cardiology
Nephrology
Autoimmune Diseases
Drug Testing/Pharmacogenomics
HIV/AIDS
Others
|
